Suriname

Reimbursed Care Access

Suriname maintains a restrictive national drug-control framework (Wet Verdovende Middelen) that places classical psychedelics and empathogens in its most controlled categories; recreational and non‑medical possession, trafficking and manufacture carry severe penalties. Medical use of dissociative anesthetics (ketamine) exists within the national formulary and hospital practice for anesthesia and emergency medicine, but there is no formal regulatory pathway, reimbursement program, or national approval for psychedelic‑assisted therapies (psilocybin, MDMA, DMT, 5‑MeO‑DMT, ibogaine, ayahuasca, mescaline, 2C‑X) or for esketamine nasal spray (Spravato).